0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Bacteriophage Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-28C13407
Home | Market Reports | Science| Biological Sciences
Global Bacteriophage Therapy Market Research Report 2023
BUY CHAPTERS

Bacteriophage Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-28C13407
Report
October 2024
Pages:157
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bacteriophage Therapy - Market Size

The global market for Bacteriophage Therapy was estimated to be worth US$ 32 million in 2023 and is forecast to a readjusted size of US$ 62 million by 2030 with a CAGR of 9.6% during the forecast period 2024-2030

Bacteriophage Therapy - Market

Bacteriophage Therapy - Market

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bacteriophage Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bacteriophage Therapy by region & country, by Type, and by Application.
The Bacteriophage Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage Therapy.
Market Segmentation

Scope of Bacteriophage Therapy - Market Report

Report Metric Details
Report Name Bacteriophage Therapy - Market
Forecasted market size in 2030 US$ 62 million
CAGR 9.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Oral
  • Topical
  • Parenteral
Segment by Application
  • Organ Transplantation
  • Bacterial Infections
  • Alcoholic Hepatitis
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Inc., EnBiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Bacteriophage Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Bacteriophage Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Bacteriophage Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Bacteriophage Therapy - Market size in 2030?

Ans: The Bacteriophage Therapy - Market size in 2030 will be US$ 62 million.

Who are the main players in the Bacteriophage Therapy - Market report?

Ans: The main players in the Bacteriophage Therapy - Market are Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Inc., EnBiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation

What are the Application segmentation covered in the Bacteriophage Therapy - Market report?

Ans: The Applications covered in the Bacteriophage Therapy - Market report are Organ Transplantation, Bacterial Infections, Alcoholic Hepatitis, Other

What are the Type segmentation covered in the Bacteriophage Therapy - Market report?

Ans: The Types covered in the Bacteriophage Therapy - Market report are Oral, Topical, Parenteral

1 Market Overview
1.1 Bacteriophage Therapy Product Introduction
1.2 Global Bacteriophage Therapy Market Size Forecast
1.3 Bacteriophage Therapy Market Trends & Drivers
1.3.1 Bacteriophage Therapy Industry Trends
1.3.2 Bacteriophage Therapy Market Drivers & Opportunity
1.3.3 Bacteriophage Therapy Market Challenges
1.3.4 Bacteriophage Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bacteriophage Therapy Players Revenue Ranking (2023)
2.2 Global Bacteriophage Therapy Revenue by Company (2019-2024)
2.3 Key Companies Bacteriophage Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Bacteriophage Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Bacteriophage Therapy
2.6 Bacteriophage Therapy Market Competitive Analysis
2.6.1 Bacteriophage Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Bacteriophage Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Topical
3.1.3 Parenteral
3.2 Global Bacteriophage Therapy Sales Value by Type
3.2.1 Global Bacteriophage Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bacteriophage Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Bacteriophage Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Organ Transplantation
4.1.2 Bacterial Infections
4.1.3 Alcoholic Hepatitis
4.1.4 Other
4.2 Global Bacteriophage Therapy Sales Value by Application
4.2.1 Global Bacteriophage Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bacteriophage Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Bacteriophage Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Bacteriophage Therapy Sales Value by Region
5.1.1 Global Bacteriophage Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bacteriophage Therapy Sales Value by Region (2019-2024)
5.1.3 Global Bacteriophage Therapy Sales Value by Region (2025-2030)
5.1.4 Global Bacteriophage Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Bacteriophage Therapy Sales Value, 2019-2030
5.2.2 North America Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Bacteriophage Therapy Sales Value, 2019-2030
5.3.2 Europe Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Bacteriophage Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Bacteriophage Therapy Sales Value, 2019-2030
5.5.2 South America Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Bacteriophage Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bacteriophage Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bacteriophage Therapy Sales Value
6.3 United States
6.3.1 United States Bacteriophage Therapy Sales Value, 2019-2030
6.3.2 United States Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bacteriophage Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bacteriophage Therapy Sales Value, 2019-2030
6.4.2 Europe Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bacteriophage Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bacteriophage Therapy Sales Value, 2019-2030
6.5.2 China Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bacteriophage Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bacteriophage Therapy Sales Value, 2019-2030
6.6.2 Japan Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bacteriophage Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bacteriophage Therapy Sales Value, 2019-2030
6.7.2 South Korea Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bacteriophage Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bacteriophage Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bacteriophage Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bacteriophage Therapy Sales Value, 2019-2030
6.9.2 India Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bacteriophage Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Armata Pharmaceuticals, Inc.
7.1.1 Armata Pharmaceuticals, Inc. Profile
7.1.2 Armata Pharmaceuticals, Inc. Main Business
7.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Products, Services and Solutions
7.1.4 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Armata Pharmaceuticals, Inc. Recent Developments
7.2 Eliava Biopreparations Ltd.
7.2.1 Eliava Biopreparations Ltd. Profile
7.2.2 Eliava Biopreparations Ltd. Main Business
7.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Products, Services and Solutions
7.2.4 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Eliava Biopreparations Ltd. Recent Developments
7.3 Pherecydes Pharma
7.3.1 Pherecydes Pharma Profile
7.3.2 Pherecydes Pharma Main Business
7.3.3 Pherecydes Pharma Bacteriophage Therapy Products, Services and Solutions
7.3.4 Pherecydes Pharma Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Intralytix, Inc. Recent Developments
7.4 Intralytix, Inc.
7.4.1 Intralytix, Inc. Profile
7.4.2 Intralytix, Inc. Main Business
7.4.3 Intralytix, Inc. Bacteriophage Therapy Products, Services and Solutions
7.4.4 Intralytix, Inc. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Intralytix, Inc. Recent Developments
7.5 Phagelux Inc.
7.5.1 Phagelux Inc. Profile
7.5.2 Phagelux Inc. Main Business
7.5.3 Phagelux Inc. Bacteriophage Therapy Products, Services and Solutions
7.5.4 Phagelux Inc. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Phagelux Inc. Recent Developments
7.6 Nextbiotics
7.6.1 Nextbiotics Profile
7.6.2 Nextbiotics Main Business
7.6.3 Nextbiotics Bacteriophage Therapy Products, Services and Solutions
7.6.4 Nextbiotics Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Nextbiotics Recent Developments
7.7 InnoPhage, Ltd
7.7.1 InnoPhage, Ltd Profile
7.7.2 InnoPhage, Ltd Main Business
7.7.3 InnoPhage, Ltd Bacteriophage Therapy Products, Services and Solutions
7.7.4 InnoPhage, Ltd Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 InnoPhage, Ltd Recent Developments
7.8 Locus Biosciences, Inc.
7.8.1 Locus Biosciences, Inc. Profile
7.8.2 Locus Biosciences, Inc. Main Business
7.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Products, Services and Solutions
7.8.4 Locus Biosciences, Inc. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Locus Biosciences, Inc. Recent Developments
7.9 TechnoPhage
7.9.1 TechnoPhage Profile
7.9.2 TechnoPhage Main Business
7.9.3 TechnoPhage Bacteriophage Therapy Products, Services and Solutions
7.9.4 TechnoPhage Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 TechnoPhage Recent Developments
7.10 Eligo Bioscience SA
7.10.1 Eligo Bioscience SA Profile
7.10.2 Eligo Bioscience SA Main Business
7.10.3 Eligo Bioscience SA Bacteriophage Therapy Products, Services and Solutions
7.10.4 Eligo Bioscience SA Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Eligo Bioscience SA Recent Developments
7.11 Phagomed Biopharma GmbH.
7.11.1 Phagomed Biopharma GmbH. Profile
7.11.2 Phagomed Biopharma GmbH. Main Business
7.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Products, Services and Solutions
7.11.4 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 Phagomed Biopharma GmbH. Recent Developments
7.12 PhagePro, Inc.
7.12.1 PhagePro, Inc. Profile
7.12.2 PhagePro, Inc. Main Business
7.12.3 PhagePro, Inc. Bacteriophage Therapy Products, Services and Solutions
7.12.4 PhagePro, Inc. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.12.5 PhagePro, Inc. Recent Developments
7.13 Adaptive Phage Therapeutics, Inc.
7.13.1 Adaptive Phage Therapeutics, Inc. Profile
7.13.2 Adaptive Phage Therapeutics, Inc. Main Business
7.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Products, Services and Solutions
7.13.4 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.13.5 Adaptive Phage Therapeutics, Inc. Recent Developments
7.14 EnBiotix, Inc.
7.14.1 EnBiotix, Inc. Profile
7.14.2 EnBiotix, Inc. Main Business
7.14.3 EnBiotix, Inc. Bacteriophage Therapy Products, Services and Solutions
7.14.4 EnBiotix, Inc. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.14.5 EnBiotix, Inc. Recent Developments
7.15 Intodeworld, Inc.
7.15.1 Intodeworld, Inc. Profile
7.15.2 Intodeworld, Inc. Main Business
7.15.3 Intodeworld, Inc. Bacteriophage Therapy Products, Services and Solutions
7.15.4 Intodeworld, Inc. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.15.5 Intodeworld, Inc. Recent Developments
7.16 BiomX Ltd.
7.16.1 BiomX Ltd. Profile
7.16.2 BiomX Ltd. Main Business
7.16.3 BiomX Ltd. Bacteriophage Therapy Products, Services and Solutions
7.16.4 BiomX Ltd. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.16.5 BiomX Ltd. Recent Developments
7.17 Phi Therapeutics
7.17.1 Phi Therapeutics Profile
7.17.2 Phi Therapeutics Main Business
7.17.3 Phi Therapeutics Bacteriophage Therapy Products, Services and Solutions
7.17.4 Phi Therapeutics Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.17.5 Phi Therapeutics Recent Developments
7.18 Fixed-phage Ltd.
7.18.1 Fixed-phage Ltd. Profile
7.18.2 Fixed-phage Ltd. Main Business
7.18.3 Fixed-phage Ltd. Bacteriophage Therapy Products, Services and Solutions
7.18.4 Fixed-phage Ltd. Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.18.5 Fixed-phage Ltd. Recent Developments
7.19 Micreos BV
7.19.1 Micreos BV Profile
7.19.2 Micreos BV Main Business
7.19.3 Micreos BV Bacteriophage Therapy Products, Services and Solutions
7.19.4 Micreos BV Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.19.5 Micreos BV Recent Developments
7.20 ContraFect Corporation
7.20.1 ContraFect Corporation Profile
7.20.2 ContraFect Corporation Main Business
7.20.3 ContraFect Corporation Bacteriophage Therapy Products, Services and Solutions
7.20.4 ContraFect Corporation Bacteriophage Therapy Revenue (US$ Million) & (2019-2024)
7.20.5 ContraFect Corporation Recent Developments
8 Industry Chain Analysis
8.1 Bacteriophage Therapy Industrial Chain
8.2 Bacteriophage Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bacteriophage Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Bacteriophage Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Bacteriophage Therapy Market Trends
    Table 2. Bacteriophage Therapy Market Drivers & Opportunity
    Table 3. Bacteriophage Therapy Market Challenges
    Table 4. Bacteriophage Therapy Market Restraints
    Table 5. Global Bacteriophage Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bacteriophage Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Bacteriophage Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Bacteriophage Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Bacteriophage Therapy
    Table 10. Global Bacteriophage Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Bacteriophage Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Bacteriophage Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Bacteriophage Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Bacteriophage Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Bacteriophage Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Bacteriophage Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Bacteriophage Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Bacteriophage Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Bacteriophage Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Bacteriophage Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Bacteriophage Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Bacteriophage Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Bacteriophage Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Bacteriophage Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Bacteriophage Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Bacteriophage Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Bacteriophage Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Bacteriophage Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Armata Pharmaceuticals, Inc. Basic Information List
    Table 32. Armata Pharmaceuticals, Inc. Description and Business Overview
    Table 33. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Bacteriophage Therapy Business of Armata Pharmaceuticals, Inc. (2019-2024)
    Table 35. Armata Pharmaceuticals, Inc. Recent Developments
    Table 36. Eliava Biopreparations Ltd. Basic Information List
    Table 37. Eliava Biopreparations Ltd. Description and Business Overview
    Table 38. Eliava Biopreparations Ltd. Bacteriophage Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Bacteriophage Therapy Business of Eliava Biopreparations Ltd. (2019-2024)
    Table 40. Eliava Biopreparations Ltd. Recent Developments
    Table 41. Pherecydes Pharma Basic Information List
    Table 42. Pherecydes Pharma Description and Business Overview
    Table 43. Pherecydes Pharma Bacteriophage Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Bacteriophage Therapy Business of Pherecydes Pharma (2019-2024)
    Table 45. Pherecydes Pharma Recent Developments
    Table 46. Intralytix, Inc. Basic Information List
    Table 47. Intralytix, Inc. Description and Business Overview
    Table 48. Intralytix, Inc. Bacteriophage Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Bacteriophage Therapy Business of Intralytix, Inc. (2019-2024)
    Table 50. Intralytix, Inc. Recent Developments
    Table 51. Phagelux Inc. Basic Information List
    Table 52. Phagelux Inc. Description and Business Overview
    Table 53. Phagelux Inc. Bacteriophage Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Bacteriophage Therapy Business of Phagelux Inc. (2019-2024)
    Table 55. Phagelux Inc. Recent Developments
    Table 56. Nextbiotics Basic Information List
    Table 57. Nextbiotics Description and Business Overview
    Table 58. Nextbiotics Bacteriophage Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Bacteriophage Therapy Business of Nextbiotics (2019-2024)
    Table 60. Nextbiotics Recent Developments
    Table 61. InnoPhage, Ltd Basic Information List
    Table 62. InnoPhage, Ltd Description and Business Overview
    Table 63. InnoPhage, Ltd Bacteriophage Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Bacteriophage Therapy Business of InnoPhage, Ltd (2019-2024)
    Table 65. InnoPhage, Ltd Recent Developments
    Table 66. Locus Biosciences, Inc. Basic Information List
    Table 67. Locus Biosciences, Inc. Description and Business Overview
    Table 68. Locus Biosciences, Inc. Bacteriophage Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Bacteriophage Therapy Business of Locus Biosciences, Inc. (2019-2024)
    Table 70. Locus Biosciences, Inc. Recent Developments
    Table 71. TechnoPhage Basic Information List
    Table 72. TechnoPhage Description and Business Overview
    Table 73. TechnoPhage Bacteriophage Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Bacteriophage Therapy Business of TechnoPhage (2019-2024)
    Table 75. TechnoPhage Recent Developments
    Table 76. Eligo Bioscience SA Basic Information List
    Table 77. Eligo Bioscience SA Description and Business Overview
    Table 78. Eligo Bioscience SA Bacteriophage Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Bacteriophage Therapy Business of Eligo Bioscience SA (2019-2024)
    Table 80. Eligo Bioscience SA Recent Developments
    Table 81. Phagomed Biopharma GmbH. Basic Information List
    Table 82. Phagomed Biopharma GmbH. Description and Business Overview
    Table 83. Phagomed Biopharma GmbH. Bacteriophage Therapy Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Bacteriophage Therapy Business of Phagomed Biopharma GmbH. (2019-2024)
    Table 85. Phagomed Biopharma GmbH. Recent Developments
    Table 86. PhagePro, Inc. Basic Information List
    Table 87. PhagePro, Inc. Description and Business Overview
    Table 88. PhagePro, Inc. Bacteriophage Therapy Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Bacteriophage Therapy Business of PhagePro, Inc. (2019-2024)
    Table 90. PhagePro, Inc. Recent Developments
    Table 91. Adaptive Phage Therapeutics, Inc. Basic Information List
    Table 92. Adaptive Phage Therapeutics, Inc. Description and Business Overview
    Table 93. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Bacteriophage Therapy Business of Adaptive Phage Therapeutics, Inc. (2019-2024)
    Table 95. Adaptive Phage Therapeutics, Inc. Recent Developments
    Table 96. EnBiotix, Inc. Basic Information List
    Table 97. EnBiotix, Inc. Description and Business Overview
    Table 98. EnBiotix, Inc. Bacteriophage Therapy Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Bacteriophage Therapy Business of EnBiotix, Inc. (2019-2024)
    Table 100. EnBiotix, Inc. Recent Developments
    Table 101. Intodeworld, Inc. Basic Information List
    Table 102. Intodeworld, Inc. Description and Business Overview
    Table 103. Intodeworld, Inc. Bacteriophage Therapy Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Bacteriophage Therapy Business of Intodeworld, Inc. (2019-2024)
    Table 105. Intodeworld, Inc. Recent Developments
    Table 106. BiomX Ltd. Basic Information List
    Table 107. BiomX Ltd. Description and Business Overview
    Table 108. BiomX Ltd. Bacteriophage Therapy Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Bacteriophage Therapy Business of BiomX Ltd. (2019-2024)
    Table 110. BiomX Ltd. Recent Developments
    Table 111. Phi Therapeutics Basic Information List
    Table 112. Phi Therapeutics Description and Business Overview
    Table 113. Phi Therapeutics Bacteriophage Therapy Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Bacteriophage Therapy Business of Phi Therapeutics (2019-2024)
    Table 115. Phi Therapeutics Recent Developments
    Table 116. Fixed-phage Ltd. Basic Information List
    Table 117. Fixed-phage Ltd. Description and Business Overview
    Table 118. Fixed-phage Ltd. Bacteriophage Therapy Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Bacteriophage Therapy Business of Fixed-phage Ltd. (2019-2024)
    Table 120. Fixed-phage Ltd. Recent Developments
    Table 121. Micreos BV Basic Information List
    Table 122. Micreos BV Description and Business Overview
    Table 123. Micreos BV Bacteriophage Therapy Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Bacteriophage Therapy Business of Micreos BV (2019-2024)
    Table 125. Micreos BV Recent Developments
    Table 126. ContraFect Corporation Basic Information List
    Table 127. ContraFect Corporation Description and Business Overview
    Table 128. ContraFect Corporation Bacteriophage Therapy Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Bacteriophage Therapy Business of ContraFect Corporation (2019-2024)
    Table 130. ContraFect Corporation Recent Developments
    Table 131. Key Raw Materials Lists
    Table 132. Raw Materials Key Suppliers Lists
    Table 133. Bacteriophage Therapy Downstream Customers
    Table 134. Bacteriophage Therapy Distributors List
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
    Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Bacteriophage Therapy Product Picture
    Figure 2. Global Bacteriophage Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bacteriophage Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Bacteriophage Therapy Report Years Considered
    Figure 5. Global Bacteriophage Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Bacteriophage Therapy Revenue in 2023
    Figure 7. Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Oral Picture
    Figure 9. Topical Picture
    Figure 10. Parenteral Picture
    Figure 11. Global Bacteriophage Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Bacteriophage Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Organ Transplantation
    Figure 14. Product Picture of Bacterial Infections
    Figure 15. Product Picture of Alcoholic Hepatitis
    Figure 16. Product Picture of Other
    Figure 17. Global Bacteriophage Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Bacteriophage Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Bacteriophage Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Bacteriophage Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Bacteriophage Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Bacteriophage Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Bacteriophage Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Bacteriophage Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Bacteriophage Therapy Sales Value (%), (2019-2030)
    Figure 30. United States Bacteriophage Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Bacteriophage Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Bacteriophage Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Bacteriophage Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Bacteriophage Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Bacteriophage Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Bacteriophage Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Bacteriophage Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Bacteriophage Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Bacteriophage Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Bacteriophage Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Bacteriophage Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Bacteriophage Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Bacteriophage Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Bacteriophage Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 51. Bacteriophage Therapy Industrial Chain
    Figure 52. Bacteriophage Therapy Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

DNA And RNA Synthesis Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-8T14376
Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Bacteriophage Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28C13407
Thu Oct 24 00:00:00 UTC 2024

Add to Cart

Special Enzyme - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-18K8098
Thu Oct 24 00:00:00 UTC 2024

Add to Cart

Global AI Protein Design Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17B18638
Thu Oct 24 00:00:00 UTC 2024

Add to Cart